Melsmon

Description

Melsmon Injection is a pharmaceutical-grade human placental extract produced by Japan Bio Products Co., Ltd. (JBP), made from carefully screened, safe human placenta through a proprietary enzymatic hydrolysis and purification process. Each 2 mL ampoule contains 100 mg of placental hydrolysate, rich in low-molecular-weight peptides, amino acids, nucleic acids, vitamins, minerals, trace elements, growth factors, and glycosaminoglycans—delivered in a sterile, injectable form.

Melsmon has been used clinically in Japan and other Asian countries since the 1950s, originally approved for menopausal symptoms, chronic fatigue, liver dysfunction, and impaired lactation. Over decades, it has become a cornerstone of integrative, aesthetic, and regenerative medicine for its broad-spectrum rejuvenating and restorative effects, including:

• Stimulation of cellular regeneration and tissue repair
• Enhancement of immune function and antioxidant capacity
• Improvement in skin elasticity, hydration, brightness, firmness, and texture (via collagen/elastin support and melanin regulation)
• Reduction of menopausal symptoms (hot flashes, fatigue, mood swings, sleep disturbance)
• Boost in energy levels, stamina, and recovery from stress, illness, or overwork
• Support for liver detoxification, metabolic balance, and hormonal regulation
• Anti-inflammatory and immunomodulatory properties

Common Administration Protocols

• IV Drip — Most popular for systemic rejuvenation: 1–4 ampoules (100–400 mg) diluted in 100–250 mL saline or glucose, infused over 30–60 minutes; typically 1–3 sessions per week for 4–12 weeks, followed by maintenance
• Intramuscular Injection — 1–2 ampoules per session for general wellness, fatigue, or menopausal support
• Mesotherapy / Micro-needling — Diluted Melsmon combined with HA, vitamins, or other boosters for facial/neck/décolleté/hand rejuvenation, skin brightening, anti-aging, scar improvement, and glow
• Combination Therapies — Frequently paired with glutathione, vitamin C, B-complex, or other IV nutrients in high-end wellness drips

Results are often cumulative: patients commonly report increased energy, better sleep, clearer/more radiant skin, reduced pigmentation, improved mood, and overall vitality after 4–8 weeks of consistent use. Skin benefits (glow, firmness, even tone, reduced fine lines) are especially pronounced when used in facial mesotherapy or combined with microneedling/RF treatments.

Safety & Side Effects

Melsmon has a long history of safe clinical use in Japan with a very low incidence of adverse reactions when administered properly. Common transient side effects include mild injection-site pain, redness, or swelling (IM/IV), or temporary fatigue/headache after high-dose IV sessions. Rare reactions may include allergic responses (due to human-derived material), transient fever, or mild gastrointestinal upset—proper screening and slow infusion minimize risks.

As of 2026, Melsmon is approved in Japan for menopausal disorders, lactation support, and liver dysfunction and is widely used off-label in aesthetic, regenerative, and anti-aging medicine across Asia, Europe, the Middle East, Latin America, and other regions, but it is non approuvé par la FDA in the United States. Availability occurs through compounding pharmacies, specialized clinics, or international suppliers under medical supervision.

Melsmon Injection should only be administered by qualified healthcare professionals (doctors trained in IV therapy, aesthetic medicine, or regenerative treatments) after thorough medical screening (liver function, allergies, infectious disease history). It is contraindicated in active malignancy, severe autoimmune disease, or known hypersensitivity to placental extracts. Always combine Melsmon with a holistic approach—nutrition, hydration, sleep, exercise, and stress management—for optimal rejuvenation and wellness results. Consult a licensed provider for a personalized assessment, proper dosing protocol, and to ensure safe, sterile administration.